http://altimmune.com
Altimmune, Inc. Company Intro
Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for liver disease and immune modulating therapies. Our diverse pipeline includes treatments for NASH (ALT-801), chronic Hepatitis B, and conjugated immunostimulants for the treatment of cancer. In addition, we are developing intranasal vaccine & therapeutic candidates for anthrax, influenza and COVID-19.
Industry
Healthcare
Altimmune, Inc. Headquaters
910 Clopper Road
Gaithersburg,20878
United States
Altimmune, Inc. Share price
22 Apr 2021 01:04 GMT
$11.78
-0.03 (-0.25 %)
Altimmune, Inc. Market cap
$461.779 M
WMC RANKING
2021
Altimmune, Inc. # 191
BiotechnologyLatest Altimmune, Inc. News
16 Apr 2021
Altimmune Inc. (ALT): The stock medium term indicators say ...
Altimmune Inc. (ALT) saw downtrend of -1.70% in the recent trading with $12.73 being its most recent. The current price level -63.73% lower than the highest ...
17 Apr 2021
Global Measle Vaccine Market Size, Share, Growth ...
Market Research Inc recently Adds New Market Research Analysis Report Measle Vaccine 2021-2028.The extensive examination on the Measle Vaccine market ...
16 Apr 2021
Altimmune Inc. (ALT): The stock medium term indicators say ...
Altimmune Inc. (ALT) saw downtrend of -1.70% in the recent trading with $12.73 being its most recent. The current price level -63.73% lower than the highest ...
WMC Market Score
WMC Market to Revenue Score
Altimmune, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Altimmune, Inc. | USD | $8,185 | $62,984 | $-49,044 | $4,618M | 191 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $542,600B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,205,683 | $2,599,993 | $2,711,647 | $568,780B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,069,900 | $2,656,500 | $603,400 | $367,910B | 3 |
| Incyte Corporation | USD | $2,229,409 | $1,622,822 | $446,906 | $186,280B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Altimmune, Inc. Social Followers vs Top 4 Industry Competitors
Altimmune, Inc. Post vs Top 4 Industry Competitors
Altimmune, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Altimmune, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Altimmune, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Altimmune, Inc. | 0.09 | 1.31 | 0.02 | 0 | 0 | 0 | 0.51 |
| Regeneron Pharmaceuticals, Inc. | 100 | 23.95 | 7.31 | 100 | 0 | 0 | 50.46 |
| Vertex Pharmaceuticals Incorporated | 67.14 | 35.08 | 2.43 | 86 | 0 | 0 | 47.42 |
| Alexion Pharmaceuticals, Inc. | 65.67 | 100 | 100 | 60 | 0 | 0 | 100 |
| Incyte Corporation | 24.12 | 4.95 | 0.18 | 2 | 0 | 0 | 2.90 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
